Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
Figure 1
Rapid and maintained improvement of macular thickness (1 mm central retinal thickness, macular cube strategy , and Cirrus-HD OCT) following the onset of Golimumab (data expressed as mean values compared with basal results).